By Lisa Kerner
Charlotte, N.C., Aug. 16 - Cempra Pharmaceuticals, Inc. said it has closed a $14 million round of series A financing.
Proceeds will be used to expand Cempra's antibiotic product development and to grow the company's portfolio of products.
Venture capital firm Intersouth Partners and investment banker I. Wistar Morris, III co-led the round.
Garheng Kong of Intersouth Partners will join Morris on Cempra's board of directors.
Cempra is a biotechnology company located in Research Triangle Park, N.C.
| Issuer: | Cempra Pharmaceuticals, Inc.
|
| Issue: | Series A financing
|
| Amount: | $14 million
|
| Investors: | Intersouth Partners, I. Wistar Morris, III (co-lead)
|
| Announcement date: | Aug. 16
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
